The benefits of HIV treatment: undetectable means you do not pass on the virus
Since its introduction in the 1990s, the main aim of combination antiretroviral therapy (ART) for HIV has been to halt the progression of the infection, maintaining the health of the HIV-positive person taking treatment. In addition to this, the impact of treatment as prevention has been well described.
Taking stock: where does Europe stand in the elimination of hepatitis B and C?
In 2016, a regional action plan for Europe that aims to contribute to the implementation of the global viral hepatitis elimination strategy was developed by the WHO Regional Office for Europe. In an article published today in Eurosurveillance, the authors take a closer look how Europe is doing according to the ten indicators and targets outlined in this plan. In short: Europe still has some way to go if it wants to eliminate viral hepatitis by 2030.
Pre-exposure prophylaxis to prevent HIV among MSM in Europe
The results of two clinical studies, PROUD and IPERGAY, suggests that the use of pre-exposure prophylaxis (PrEP) for men who have sex with men (MSM) is an effective HIV prevention tool for Europe.
Decline in early childhood respiratory tract infections in the norwegian mother and child cohort study after introduction of pneumococcal conjugate vaccinationArchived
The study design and analysis controlled for influence of potentially confounding trends, such as improvement of day-care carriage and decreasing prevalence of smoking during the study period.
Facemasks and good hand hygiene to reduce influenza transmission in households – Cluster Randomised Controlled Trial in GermanyArchived
Facemasks and good hand hygiene to reduce influenza transmission in households – Cluster Randomised Controlled Trial in Germany
Accelerating Control of Pertussis in England and WalesArchived
Despite a reduction in pertussis among younger children and infants, rates of pertussis-related sickness and death remain high compared with rates for other vaccine-preventable diseases in England and Wales.
New (Post Pandemic 2009) UK Influenza Pandemic Preparedness StrategyArchived
Following an earlier consultation document issued in March 2011 the UK’s Secretary of State for Health, along with the UK’s developed administrations (N. Ireland, Scotland and Wales) published a new influenza pandemic strategy on 10 November.
Global estimates of the direct burden of influenza on the health of younger children (under age 5 years) including separate estimates for the European RegionArchived
It is accompanied by an editorial comment from Maria Zambon of the UK Health Protection Agency add link pleaseThis comprehensive study published by an international group attempts to estimate the global incidence of lower respiratory infections and premature deaths associated with influenza in children younger than 5 years.
Rubella revisited: Where are we on the road to disease elimination in Central Europe?Archived
Elimination of rubella and prevention of congenital rubella infection in Europe has been a high priority for the WHO European Regional Office over the past decade. In 2010 the WHO regional committee for Europe renewed its commitment to the elimination of rubella and prevention of CRS with a new target of 2015. For Central Europe to reach the target of rubella elimination and prevention of CRS by 2015, very high vaccine coverage levels need to be maintained and catch-up campaigns continued to address susceptible groups, in particular women of child-bearing age.